# \[e-drug\] Medicines for Europe and the World: Setting Priorities, Missing the Point

**URL:** <https://talk.edrugplus.org/t/e-drug-medicines-for-europe-and-the-world-setting-priorities-missing-the-point/20563>\
**Category:** e-drug\
**Created:** [September 27, 2004, 7:59am UTC](https://talk.edrugplus.org/t/e-drug-medicines-for-europe-and-the-world-setting-priorities-missing-the-point/20563 "2004-09-27T07:59:09Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Jeremy\_Smith](https://avatars.discourse-cdn.com/v4/letter/j/a5b964/32.png) [@Jeremy\_Smith](https://talk.edrugplus.org/u/Jeremy_Smith)\
**Post date:** [September 27, 2004, 7:59am UTC](https://talk.edrugplus.org/t/e-drug-medicines-for-europe-and-the-world-setting-priorities-missing-the-point/20563/1 "2004-09-27T07:59:09Z")

</div>

E-DRUG: Meds for Europe and the World: Setting Priorities, Missing the Point  
---------------------------------------------------------------------------

Health Action International (HAI) Europe is pleased to invite you to a  
meeting Medicines for Europe and the World: Setting Priorities, Missing  
the Point, to be held in The Hague on the morning of 18 November.

HAI Europe and representatives of partner organisations will detail  
their concerns about the process and driving purpose of the Dutch  
Presidency-sponsored conference on Priority Medicines for the Citizens  
of Europe, which begins later the same day.

HAI Europe believes strongly that the Priority Medicines project misses  
the point in two key areas:

1. Medicines for Europe: too much trust is placed in the  
pharmaceutical industry as a generator of valuable new medicines. In  
reality, the industry does not offer value for money in its research,  
has shown itself to be rarely innovative and resorts to dubious  
promotional practices to disguise its lack of innovation.

2. Medicines for the World: tackling shortfalls in research and  
development in neglected diseases which affect millions across the world  
is conspicuous in its absence from the Priority Medicines agenda - the  
Dutch Presidency and the wider EU have to indicate how they will be  
addressing this issue, if it is not through the Priority Medicines  
initiative

The draft agenda for the meeting is attached. The meeting will take  
place in the Anton Phillip Zaal, Lucent Theatre, a short distance from  
the Nieuwe Kerk, where the Dutch Presidency meeting will take place.

Please do not hesitate to contact me if you have any queries. We very  
much hope to see you on 18 November.

Jeremy Smith

Campaigns Coordinator  
Health Action International Europe  
Jacob van Lennepkade 334-T  
1053 NJ Amsterdam  
The Netherlands  
Tel: +31 20 489 1864  
Fax: +31 20 685 5002  
email: jeremy@haiweb.org

[E-drug cannot carry attachments; send an email to jeremy@haiweb.org for the programme if you are interested; WB]
